PRINCETON, N.J., March 11, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will participate in two upcoming investor conferences, including a live panel discussion on drug development in Women’s Health.

• 
  Oppenheimer’s 32
  
  
  ^nd
  
  
  Annual Virtual Healthcare Conference
  
  • Fireside Chat
    • Thursday, March 17, 2022 at 2:00 p.m. ET

• 
  Maxim Group and M-Vest 2022 Virtual Growth Conference
  
  
  • 
    Advances in Women’s Health, from Clinical to Commercial
    
    Live Panel Discussion
    • Monday, March 28, 2022 at 3:00 p.m. ET
      

Links and webcast information for each conference can be found on the Investors section of the Agile Therapeutics website at

https://ir.agiletherapeutics.com/events-and-presentations

. Each archived webcast will be available for 30 days.

About Agile Therapeutics, Inc.


Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla

^®

, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion

^®

, which is designed to allow drug delivery through the skin. For more information, please visit the company website at

www.agiletherapeutics.com

. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

Contact: 
Matt Riley
Head of Investor Relations & Corporate Communications
[email protected]